Natural killer cells in human solid tumors (Q40110364)

17 September 2017

1 reference

title

Natural killer cells in human solid tumors (English)

1 reference

17 September 2017

2

1 reference

17 September 2017

M Introna

1

1 reference

17 September 2017

1 January 1983

1 reference

Cancer and Metastasis Reviews

17 September 2017

1 reference

17 September 2017

2

1 reference

17 September 2017

4

1 reference

17 September 2017

337-350

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00048566

17 September 2017

0 references

cites work

Immunoreactivity by intrinsic lymphoid cells in colorectal carcinoma

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF00048566

Factors affecting stimulation of natural cytotoxicity to a rat lymphoma by Corynebacterium parvum

21 January 2018

1 reference

12 December 2020

Do Natural Killer Cells Engage in Regulated Reactions Against Self to Ensure Homeostasis?

1 reference

12 December 2020

Inhibition of natural killer activity by tumor-associated lymphoid cells from ascites ovarian carcinomas

1 reference

12 December 2020

Tumoricidal activity of macrophages isolated from human ascitic and solid ovarian carcinomas: augmentation by interferon, lymphokines and endotoxin

1 reference

12 December 2020

Decline of natural nonselective cell-mediated cytotoxicity in patients with tumor progression

1 reference

12 December 2020

Human tumour—lymphocyte interactionin vitro. V. Comparison of the reactivity of tumour-infiltrating, blood and lymph-node lymphocytes with autologous tumour cells

1 reference

12 December 2020

Natural cytotoxic cells against solid tumors in mice. I. Strain and age distribution and target cell susceptibility

1 reference

12 December 2020

Lymphocyte cytotoxicity against autologous tumour biopsy cells in humans.

1 reference

12 December 2020

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Enhancement of human natural killer cell activity by interferon and antagonistic inhibition of susceptibility of target cells to lysis

1 reference

12 December 2020

Natural cell-mediated cytotoxicity in rats. II.In vivo augmentation of NK-cell activity

1 reference

12 December 2020

The relationship between cytotoxicity and prognostically significant histologic changes in lymph nodes from patients with cancer of the breast

1 reference

12 December 2020

Restricted autologous lymphocytotoxicity in lung neoplasia

1 reference

12 December 2020

Cytolytic and cytostatic activity on tumor cells of circulating human monocytes

1 reference

12 December 2020

Cellular Microcytotoxicity in Human Tumor Systems: Analysis of Results2

1 reference

12 December 2020

Cytological and functional analysis of inflammatory infiltrates in human malignant tumors. II. Functional investigations of the infiltrating inflammatory cells.

1 reference

12 December 2020

Role of alloantigens in natural killing. Allogeneic but not autologous tumor biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphcoytes

1 reference

12 December 2020

Inhibition of natural killer activity by human bronchoalveolar macrophages

1 reference

12 December 2020

Relationship between natural killer cell activity and histological features of lymphocyte infiltration and partial regression of the primary tumor in melanoma patients

1 reference

12 December 2020

Induction and kinetics of natural killer cells in humans following interferon therapy

1 reference

12 December 2020

Relationship of human natural lymphocyte-mediated cytotoxicity to cytotoxicity of breast-cancer-derived target cells

1 reference

12 December 2020

Spontaneous in vitro cytotoxicity against autochthonous human melanoma cells

1 reference

12 December 2020

Adriamycin-induced antitumor response in lethally irradiated mice

1 reference

12 December 2020

Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: limiting dilution analysis in peripheral blood and at the tumour site

1 reference

12 December 2020

A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin

1 reference

12 December 2020

Activation of human natural killer cells cytotoxic for human leukemia cells by purified interferon

1 reference

12 December 2020

Development of cytotoxic cells during in vitro cultures of pleural effusion lymphocytes from patients with lung cancer

1 reference

12 December 2020

Defective natural killer activity within human ovarian tumors: low numbers of morphologically defined effectors present in situ

1 reference

12 December 2020

Mononuclear-cell infiltration in ovarian cancer. II. Immune function of tumour and ascites-derived inflammatory cells

1 reference

12 December 2020

Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days. II. Changes in non-specific (NK, K and T cell) lymphocytoxicity and delayed hypersensitivity skin reactio

1 reference

12 December 2020

Morphological and Functional Characterization of Isolated Effector Cells Responsible for Human Natural Killer Activity to Fetal Fibroblasts and to Cultured Cell Line Targets

1 reference

12 December 2020

Modulation of target cell susceptibility to human natural killer cells by interferon

1 reference

12 December 2020

Suppressor cells of immune reactivity in malignancy

1 reference

12 December 2020

Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells

1 reference

12 December 2020

Suppressor cell activity of lymphocytes infiltrating human lung and breast tumours

1 reference

12 December 2020

Prostaglandin synthesis inhibitors potentiate the BCG-induced augmentation of natural killer cell activity

1 reference

12 December 2020

Human natural cytotoxicity in the blood and lymphoid organs of healthy donors and patients with malignant disease

1 reference

12 December 2020

Natural cytotoxicity of mouse monocytes and macrophages

1 reference

12 December 2020

Generation of suppressor cells for natural killer activity in cancer patients after surgery

1 reference

12 December 2020

Spontaneous human lymphocyte-mediated cytotoxicity againts tumour target cells. I. The effect of malignant disease

1 reference

12 December 2020

Human natural cell-mediated cytotoxicity against fetal fibroblasts. III. Morphological and functional characterization of the effector cells

1 reference

12 December 2020

Destruction of human lymphoid tissue-culture cell lines by human peripheral lymphocytes in 51Cr-release cellular cytotoxicity assays

1 reference

12 December 2020

Specific T-cell-mediated killing of autologous lung tumour cells

1 reference

12 December 2020

Cytological and functional analysis of inflammatory infiltrates in human malignant tumors. III. Further functional investigations using cultured autochthonous tumor cell lines and freeze-thawed infiltrating inflammatory cells

1 reference

12 December 2020

Natural cytotoxic cells against solid tumors in mice. II. Some characteristics of the effector cells

1 reference

12 December 2020

Influence of non-specific immunologic factors on prognosis in advanced bronchogenic carcinoma

1 reference

12 December 2020

Interferon and natural killer activity in multiple myeloma. Lack of correlation between interferon-induced enhancement of natural killer activity and clinical response to human interferon-alpha

1 reference

12 December 2020

Isolation of human NK cells by density gradient centrifugation

1 reference

12 December 2020

Natural cytotoxicity in man: activity of lymph node and tumor-infiltrating lymphocytes

1 reference

12 December 2020

Effect of Chemotherapeutic Agents on Natural Cell-Mediated Cytotoxicity in Mice2

1 reference

12 December 2020

Extravascular natural cytotoxicity in man: Anti-K562 activity of lymph-node and tumour-infiltrating lymphocytes

1 reference

12 December 2020

Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation

1 reference

12 December 2020

Clinical and immunological studies of human fibroblast interferon

1 reference

12 December 2020

Interferon and spontaneous cytotoxicity in man. V. Enhancement of spontaneous cytotoxicity in patients receiving human leukocyte interferon

1 reference

12 December 2020

Immunologic evaluation of long-term effects of childhood ALL chemotherapy: analysis of in vitro NK- and K-cell activities of peripheral blood lymphocytes

1 reference

12 December 2020

Natural Cell-Mediated Immunity

1 reference

12 December 2020

Systemic administration of human leukocyte interferon to melanoma patients. II. Cellular events associated with changes in natural killer cytotoxicity

1 reference

12 December 2020

Natural cytotoxicity in humans: susceptibility of freshly isolatd tumor cells to lysis

1 reference

12 December 2020

Lymphocyte-mediated lysis of tumor cells in vitro antigen-restricted clonal and unrestricted polyclonal effects

1 reference

12 December 2020

1 reference

12 December 2020

Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells

1 reference

12 December 2020

The interaction of cancer chemotherapy agents with mononuclear phagocytes.

1 reference

12 December 2020

Susceptibility of human leukaemias to cell-mediated cytotoxicity by interferon-treated allogeneic lymphocytes.

1 reference

12 December 2020

Lysis of fresh human B-lymphocyte-derived leukemia cells by interferon-activated natural killer (NK) cells

1 reference

12 December 2020

Fractionation, morphological and functional characterization of effector cells responsible for human natural killer activity against cell-line targets

1 reference

12 December 2020

Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly sequential study of melanoma patients. I. Changes in non-specific (NK, K and T cell) lymphocytotoxicity, peripheral blood counts and delayed hypersensitivity r

1 reference

12 December 2020

Systemic administration of human leukocyte interferon to melanoma patients. I. Effects on natural killer function and cell population

1 reference

12 December 2020

Natural killer cells: their roles in defenses against disease

1 reference

12 December 2020

Promonocytes have the functional characteristics of natural killer cells

1 reference

12 December 2020

Intraperitoneal administration ofcorynebacterium parvum in patients with ascitic ovarian tumors resistant to chemotherapy: Effects on cytotoxicity of tumor-associated macrophages and NK cells

1 reference

12 December 2020

A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1)

1 reference

12 December 2020

Characteristics of human large granular lymphocytes and relationship to natural killer and K cells

1 reference

12 December 2020

Effect of Leucocyte Interferon on Natural Killer Cells in Healthy Volunteers

1 reference

12 December 2020

An analysis of conditions allowingcorynebacterium parvum to cause either augmentation or inhibition of natural killer cell activity against tumor cells in mice

1 reference

12 December 2020

Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors

1 reference

12 December 2020

Cytostasis of tumor cell lines by human granulocytes.

1 reference

12 December 2020

Differential effects of an immunosuppressive fraction from ascites fluid of patients with ovarian cancer on spontaneous and antibody-dependent cytotoxicity

1 reference

12 December 2020

Reduction of suppressor cells in cancer patients treated with OK-432 immunotherapy

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00048566

1 reference

PubMed ID

6203638

Dimensions Publication ID

17 September 2017

0 references

1 reference

PubMed ID

6203638